Gene expression profiles of CMS2-epithelial/canonical colorectal cancers are largely driven by DNA copy number gains | Oncogene
Stiftelse støtter norsk medisinsk forskning med 48 millioner - Tu.no
OUH - OUS-research.no
Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies | Clinical Cancer Research
Lesernes blinkskudd - Hamar Arbeiderblad
PDF) Transcriptome instability in colorectal cancer identified by exon microarray analyses: Associations with splicing factor expression levels and patient survival
Dr Anita Sveen received the Young Investigator prize at Onkologisk Forum for her research accomplishments - K.G. Jebsen Colorectal Cancer Research Centre
Biomarker-guided therapy for colorectal cancer: strength in complexity.,Nature Reviews Clinical Oncology - X-MOL
Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer
Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer - Bruun - 2018 - Molecular Oncology - Wiley Online Library
Ny kunnskap om tarmkreft med spredning - Kreftforeningen
Vinner av årets tema-konkurranse er Anita Sveen – Skauge Forlag
Tumour-infiltrating CD8 + lymphocytes and colorectal cancer recurrence by tumour and nodal stage | British Journal of Cancer
OUH - Molecular Oncology
OUH - Group members
OUH - Molecular Oncology
Nasjonal Kreftsatsing Konferanse 2016 - 10.-11. mars - Anita Sveen - YouTube
OUH - News
Anita SVEEN | Oslo University Hospital, Oslo
OUH - OUS-research.no
OUH - Institute for Cancer Research
Preclinical drug screening identifies novel stratified treatment options according to the consensus molecular subtypes of colorectal cancer - K.G. Jebsen Colorectal Cancer Research Centre
kliniskeffektforskning hashtag on Twitter
Anita Sveen - Institutt for klinisk medisin
OUH - Molecular Oncology
Anita SVEEN | Oslo University Hospital, Oslo
